FCM

Farallon Capital Management Portfolio holdings

AUM $17.7B
1-Year Est. Return 25.69%
This Quarter Est. Return
1 Year Est. Return
+25.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.7B
AUM Growth
-$4.09B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$323M
2
+$235M
3
+$185M
4
WAB icon
Wabtec
WAB
+$180M
5
HIMS icon
Hims & Hers Health
HIMS
+$144M

Top Sells

1
+$3.4B
2
+$804M
3
+$553M
4
LBRDK icon
Liberty Broadband Class C
LBRDK
+$421M
5
ANSS
Ansys
ANSS
+$350M

Sector Composition

1 Healthcare 45.75%
2 Technology 15.89%
3 Financials 12.88%
4 Communication Services 6.89%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
126
Ardelyx
ARDX
$1.64B
$127K ﹤0.01%
23,000
DYN icon
127
Dyne Therapeutics
DYN
$2.75B
$127K ﹤0.01%
10,000
FOLD icon
128
Amicus Therapeutics
FOLD
$4.43B
$126K ﹤0.01%
16,000
EVH icon
129
Evolent Health
EVH
$421M
$118K ﹤0.01%
14,000
ALT icon
130
Altimmune
ALT
$442M
$104K ﹤0.01%
27,600
CCCC icon
131
C4 Therapeutics
CCCC
$216M
$62.2K ﹤0.01%
28,000
ANNA
132
AleAnna Inc
ANNA
$104M
$61.8K ﹤0.01%
78,400
GERN icon
133
Geron
GERN
$836M
$58.9K ﹤0.01%
43,000
IOVA icon
134
Iovance Biotherapeutics
IOVA
$937M
$56.4K ﹤0.01%
26,000
CGC
135
Canopy Growth
CGC
$450M
$43.8K ﹤0.01%
30,000
RVMDW icon
136
Revolution Medicines Inc Warrant
RVMDW
$34.1M
$36K ﹤0.01%
120,085
NVNIW icon
137
Nvni Group Limited Warrants
NVNIW
$1.89M
$27K ﹤0.01%
375,000
IRWD icon
138
Ironwood Pharmaceuticals
IRWD
$732M
$17K ﹤0.01%
13,000
AMED
139
DELISTED
Amedisys
AMED
– –
-575,000
ANSS
140
DELISTED
Ansys
ANSS
– –
-997,128
AZEK
141
DELISTED
The AZEK Co
AZEK
– –
-3,141,400
BDSX icon
142
Biodesix
BDSX
$62.7M
– –
-6,400
BRKR icon
143
Bruker
BRKR
$7.35B
– –
-5,000
BYND icon
144
Beyond Meat
BYND
$447M
– –
-19,000
SWTX
145
DELISTED
SpringWorks Therapeutics
SWTX
– –
-5,000
THRD
146
DELISTED
Third Harmonic Bio
THRD
– –
-15,361
BBOT
147
BridgeBio Oncology
BBOT
$913M
– –
-600,000
ABT icon
148
Abbott
ABT
$212B
– –
-136,000
AKRO
149
DELISTED
Akero Therapeutics
AKRO
– –
-4,000
ALNY icon
150
Alnylam Pharmaceuticals
ALNY
$47.5B
– –
0
3 4 5
6
7